These findings may be related to possibly acquired resistance to immune surveillance by the upregulation of PD-L1 and the inhibition of peritumoral and intratumoral infiltrating lymphocytes limiting T cell-mediated tumor aggression (64). This evidence concerns the gene CD274 and neoplasm.